Specialists in Complex Trials
C-Clinical operates in a wide array of medical areas, clearly demonstrating our extensive skills and commitment to advancing groundbreaking research. Our team possesses in-depth expertise in Hematology & Oncology which includes highly seasoned professionals with the acumen to execute these complex studies. Additionally, we have a strong emphasis on Immunology, Central Nervous System (CNS) Disorders & Psychiatry, as well as Endocrinology and Ophthalmology. Our proficiency also extends to innovative fields such as Cell & Gene Therapy and Rare Disease.
Hematology & Oncology
We have developed a team of specialized experts in the areas of solid tumors, and hematologic disorders including various forms of leukemia. Our team members in this area typically have years of experience and specific training with evaluations and procedures that underly each indication and treatment modality (immunotherapy, targeted kinase inhibition, cell & gene therapy, etc.).
Immunology
At C-Clinical, we pride ourselves on our extensive expertise in immunotherapy, inflammatory and auto-immune diseases. Our dedicated team is committed to advancing understanding and treatment options for patients facing these challenging health issues.
Neurology / CNS
We have conducted extensive clinical trials focusing on pain, sleep-disorders, addiction, Alzheimer's disease, Parkinson's disease, and various psychiatric disorders. These trials aim to provide valuable insights and advancements in treatment options for individuals affected by these challenging conditions.
Endocrinology
We have been incredibly fortunate to be involved in groundbreaking first-in-human studies and operate in various endocrinology indications including diabetes, metabolic disorders, and hormonal diseases. We have been involved with developing various therapies from an artificial pancreas to GLP-1 products, which have shown significant promise in managing these complex health issues effectively.
Ophthalmology
Some of our clinical trials focusing on retinal disease, dry eye conditions, and innovative gene therapy interventions have yielded major breakthroughs that could significantly enhance treatment options and patient outcomes.
Cell and Gene Therapy
We have been involved in exciting advanced therapeutic trials utilizing allogenic and autologous cell therapy (CAR-T and Stem Cell), as well as gene therapy for specific cancers and rare disease.
